These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32812106)

  • 1. ASO Author Reflections: Clinical Utility of Circulating Tumor DNA Analysis in Colorectal Cancer: Current Status.
    Xie H; Kim RD
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):890. PubMed ID: 32812106
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Circulating Tumor DNA (ctDNA) as a Potentially Practice-Changing Innovation to Evolve "Precision Onco-Surgery" in Resectable Colorectal Liver Metastases.
    Kobayashi S; Nakamura Y; Takahashi S; Taniguchi H; Yoshino T
    Ann Surg Oncol; 2021 Aug; 28(8):4756-4757. PubMed ID: 33398645
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Perioperative Genomic Profiles and Prognosis of Peripheral and Perihepatic Circulating Tumor DNA in Patients with Colorectal Liver Metastases.
    Narayan RR; Kingham TP
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):583-584. PubMed ID: 30989499
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Clinical Implications of Circulating Tumor DNA in Pancreatic Cancer Patients.
    Yamaguchi T; Uemura K; Takahashi S
    Ann Surg Oncol; 2021 Jun; 28(6):3145-3146. PubMed ID: 33393027
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.
    Baumgartner JM; Riviere P; Kurzrock R
    Ann Surg Oncol; 2020 Sep; 27(9):3268-3269. PubMed ID: 32303875
    [No Abstract]   [Full Text] [Related]  

  • 6. IMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer - intervention trial 2. Study protocol.
    Nors J; Henriksen TV; Gotschalck KA; Juul T; Søgaard J; Iversen LH; Andersen CL
    Acta Oncol; 2020 Mar; 59(3):336-341. PubMed ID: 31920137
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Cancer Surveillance With Circulating Tumor DNA Assay.
    Venook AP
    JAMA Netw Open; 2022 Mar; 5(3):e221100. PubMed ID: 35258585
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical relevance of circulating tumour DNA in colorectal cancer.
    Kong JC; Prabhakaran S; Tie J; Ramsay R; Heriot A; Warrier S
    ANZ J Surg; 2021 May; 91(5):774-775. PubMed ID: 33999530
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of cell-free DNA in predicting colorectal cancer prognosis.
    Cao B; Zhou X; Yang W; Ma J; Zhou W; Fan D; Hong L
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):39-48. PubMed ID: 28838275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASO Author Reflections: Is ctDNA Detection an Accurate Measure of the Risk of Recurrence in Patients Undergoing Neoadjuvant Treatment?
    Gögenur M; Lindbjerg Andersen C; Gögenur I
    Ann Surg Oncol; 2022 Dec; 29(13):8675. PubMed ID: 35930114
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer.
    Zhu N; Hu H; Yuan Y
    Signal Transduct Target Ther; 2022 Sep; 7(1):308. PubMed ID: 36064813
    [No Abstract]   [Full Text] [Related]  

  • 13. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
    Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
    Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
    Bachet JB; Bouché O; Taieb J; Dubreuil O; Garcia ML; Meurisse A; Normand C; Gornet JM; Artru P; Louafi S; Bonnetain F; Thirot-Bidault A; Baumgaertner I; Coriat R; Tougeron D; Lecomte T; Mary F; Aparicio T; Marthey L; Taly V; Blons H; Vernerey D; Laurent-Puig P
    Ann Oncol; 2018 May; 29(5):1211-1219. PubMed ID: 29438522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis.
    Baumgartner JM; Kurzrock R
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):772-773. PubMed ID: 30421042
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.
    Vymetalkova V; Cervena K; Bartu L; Vodicka P
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASO Author Reflections: Potential Values of Peritoneal Cell-Free Tumor DNA Testing.
    Chan CHF
    Ann Surg Oncol; 2020 Dec; 27(13):5072-5073. PubMed ID: 33078317
    [No Abstract]   [Full Text] [Related]  

  • 18. Utility of circulating tumor cells and DNA in the management of advanced colorectal cancer.
    Pan X; Zhang X
    Future Oncol; 2020 Jun; 16(18):1289-1299. PubMed ID: 32379501
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathologic Characteristics of HER2-positive Metastatic Colorectal Cancer and Detection of HER2 in Plasma Circulating Tumor DNA.
    Wei Q; Zhang Y; Gao J; Li J; Li J; Li Y; Zhou J; Lu M; Gong J; Zhang X; Shen L; Sun Y; Chang L; Wang X
    Clin Colorectal Cancer; 2019 Sep; 18(3):175-182. PubMed ID: 31227437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer.
    Yu H; Han L; Yuan J; Sun Y
    Cancer Biomark; 2020; 27(1):29-37. PubMed ID: 31658042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.